Publication Name	World Journal of Clinical Cases
Manuscript ID	62978
Country	China

Received	2021-01-22 16:26
Peer-Review Started	2021-01-22 16:31
To Make the First Decision
Return for Revision	2021-03-25 06:02
Revised	2021-03-28 17:32
Second Decision	2021-04-06 08:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-06 15:03
Articles in Press	2021-04-06 15:03
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-04-13 23:18
Typeset the Manuscript	2021-04-28 18:01
Publish the Manuscript Online	2021-05-14 09:21

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Case Report
Article Title	Thymosin as a possible therapeutic drug for COVID-19: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Qiong Na Zheng, Mei Yan Xu, Fang Min Gan, Sha Sha Ye and Hui Zhao
Funding Agency and Grant Number	Funding Agency Grant Number Project for Science and Technology of Wenzhou Y2020278
Corresponding Author	Hui Zhao, MD, Chief Doctor, Department of Infectious Diseases, The Affiliated Yueqing Hospital, Wenzhou Medical University, No. 338 Qingyuan Street, Yueqing 325600, Zhejiang, China. 304764851@qq.com
Key Words	COVID-19; Thymosin; SARS-CoV-2; Case report; Treatment; Therapeutic drug
Core Tip	A 51-year-old Chinese man returned from Russia to Yueqing Hospital Affiliated to Wenzhou Medical University on April 27, 2020. He had 2-wk symptoms of chest pain, chest tightness, fatigue, and conscious fever. Oxygen inhalation, and thymosin was injected twice a week, at 1.6 mg per injection. The patient was successfully treated and discharged after 15 d in the hospital.
Publish Date	2021-05-14 09:21
Citation	Zheng QN, Xu MY, Gan FM, Ye SS, Zhao H. Thymosin as a possible therapeutic drug for COVID-19: A case report. World J Clin Cases 2021; 9(16): 4090-4094
URL	https://www.wjgnet.com/2307-8960/full/v9/i16/4090.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i16.4090

Full Article (PDF)	WJCC-9-4090.pdf
Full Article (Word)	WJCC-9-4090.docx
CARE Checklist–2016	62978-CARE-Checklist–2016-revision.jpg
Manuscript File	62978_Auto_Edited_LM_WangTQ.docx
Answering Reviewers	62978-Answering reviewers.pdf
Audio Core Tip	62978-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	62978-Conflict-of-interest statement.pdf
Copyright License Agreement	62978-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	62978-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	62978-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	62978-Language certificate.pdf
Peer-review Report	62978-Peer-review(s).pdf
Scientific Misconduct Check	62978-Scientific misconduct check.pdf
Scientific Editor Work List	62978-Scientific editor work list.pdf